🇮🇳IN
Sign In
GU

GUJTHEM

NSE

Gujarat Themis Biosyn Ltd

₹324.00

-29.40(-8.32%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

GUJTHEM financial summary

For Mar 2026, Gujarat Themis Biosyn Ltd reported revenue of ₹166 crore, which grew 9.9% from the previous year. Net profit was ₹47 crore, which fell 4.1% year on year, on an operating margin of 46%. Earnings per share came in at ₹4.28. Annual results are available for 16 financial years, from Mar 2011 to Mar 2026.

Revenue₹166 crore
Net profit₹47 crore
Operating margin46%
EPS₹4.28

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer